Press Releases
Search
-
14 Sep 2006
bioMérieux Award 2006 on Excellence in Pathogen Research
Ghent, Belgium - September 14, 2006. bioMérieux was proud to present its ninth Award on Pathogen Research at the “Eleventh Conference on Food Microbiology”, held this year by the University of Ghent, ...
-
01 Aug 2006
bioMérieux confirms its commitment to the fight against the AIDS virus in Africa
Marcy l'Etoile, France - August 1st, 2006. A major player in in vitro diagnostics specialized in the fight against infectious diseases, bioMérieux confirms its success in the fight against the AIDS vi...
-
18 Jul 2006
bioMérieux – First Half 2006 Sales
Marcy l'Etoile, France – July 18, 2006 – bioMérieux, a global leader in the field of in vitro diagnostics, today announced its first-half sales. Sales for the six months ended June 30, 2006 totaled €5...
-
07 Jul 2006
bioMérieux: Change in the Management Team
Marcy l'Etoile - 07/10/2006. As part of the development of bioMérieux, Alain Mérieux, President, announced today the arrival of Stéphane Bancel in the bioMérieux management team. In the coming months,...
-
27 Jun 2006
bioMérieux Sells its Hemostasis Line of Business
Marcy l'Etoile, France - June 27, 2006. bioMérieux, a global leader in the field of in vitro diagnostics, today announced the closing of the sale of its hemostasis range of products to Trinity Biotech...
-
01 Jun 2006
bioMérieux launches CampyFood ID, the first culture medium for easy detection of Campylobacter
Marcy l'Etoile, France - June 1st, 2006. bioMérieux announces a new innovation in food microbiology with CampyFood ID, the first ready-to-use culture medium for easy detection of Campylobacter in food...
-
23 May 2006
bioMérieux contributes to the fight against AIDS in the Democratic Republic of Congo
Marcy l'Etoile - 05/23/2006. bioMérieux, the world's third-largest diagnostic company in the field of infectious diseases, has won a new contract ; the company will be the exclusive provider of equipm...
-
20 May 2006
First Quarter 2006 Sales: Up 7.8% At Constant Exchange Rates
Marcy l'Etoile, France - April 20, 2006. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its sales for the first three months of 2006. Sales amounted to €255.6 millio...
-
25 Apr 2006
bioMérieux NucliSENS® easyMAG™ Receives Technology Innovation of the Year Award from Frost & Sullivan
Durham, NC, USA - April 25, 2006. 2006 Technology Innovation Award of the Year in the field of In Vitro Diagnostics. bioMérieux has been the proud recipient of 2006 Technology Innovation of the Year a...
-
10 Apr 2006
bioMérieux launches a proactive solution for Listeria risk control with VIDAS® LDUO
Marcy l'Etoile, France - April 10, 2006. bioMérieux offers food-processing industries the world’s first proactive solution for Listeria risk control with VIDAS® LDUO. VIDAS® LDUO innovation bioMérieux...
-
29 Mar 2006
ExonHit and bioMérieux reach an important research milestone in the molecular detection of breast cancer from blood samples
Marcy l'etoile and Paris, France - 03/29/2006. ExonHit Therapeutics, a French drug and diagnostic discovery company, and bioMérieux, a major player in the field of in vitro diagnostics, announce today...
-
20 Mar 2006
bioMérieux announces its results for 2005
Marcy l'Etoile, France - March 20, 2006. • Operating income up 7.3% • Net income up 13%...
-
02 Feb 2006
bioMérieux launches an avian flu test for research purposes
Marcy l'étoile, France - 02/02/2006. As a major player in the field of in vitro diagnostics, bioMérieux confirms its commitment to the fight against emerging diseases and launches its avian flu detect...
-
19 Jan 2006
2005 Sales Up 5.7% at Constant Exchange Rates
Marcy l'Etoile, France - January 19, 2006. bioMérieux, a global leader in the field of in vitro diagnostics, today announced its 2005 sales.
-
28 Nov 2005
E. coli O157: bioMérieux offers food processing industries fast, reliable detection, using VIDAS® ECO and VIDAS ICE tests
Marcy l'Etoile, France - November 28, 2005. E.coli O157 represents a major risk for consumers. It is the main cause of hemolytic uremic syndrome (HUS) that leads to acute renal failure in children. Th...